These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 2239873

  • 1. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S, Santucci L, Morelli A.
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [Abstract] [Full Text] [Related]

  • 2. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.
    Fiorucci S, Santucci L, Farroni F, Pelli MA, Morelli A.
    Am J Gastroenterol; 1989 Oct; 84(10):1263-7. PubMed ID: 2801676
    [Abstract] [Full Text] [Related]

  • 3. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Oct; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 4. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
    Can J Clin Pharmacol; 2009 Oct; 16(1):e264-72. PubMed ID: 19383986
    [Abstract] [Full Text] [Related]

  • 5. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 6. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H, Klein M, Bauer A, Arnold R.
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [Abstract] [Full Text] [Related]

  • 7. Empiric therapy for gastroesophageal reflux disease.
    Schindlbeck NE, Klauser AG, Voderholzer WA, Müller-Lissner SA.
    Arch Intern Med; 1995 Sep 11; 155(16):1808-12. PubMed ID: 7654116
    [Abstract] [Full Text] [Related]

  • 8. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep 11; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 9. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
    Tefera S, Hatlebakk JG, Berstad A.
    Am J Gastroenterol; 2001 Apr 11; 96(4):969-74. PubMed ID: 11316213
    [Abstract] [Full Text] [Related]

  • 10. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ, Strong RM.
    Dig Dis Sci; 1992 Jun 11; 37(6):897-903. PubMed ID: 1587194
    [Abstract] [Full Text] [Related]

  • 11. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun 11; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 12. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux.
    Achem SR, Kolts BE, Wears R, Burton L, Richter JE.
    Am J Gastroenterol; 1993 Feb 11; 88(2):187-92. PubMed ID: 8424418
    [Abstract] [Full Text] [Related]

  • 13. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May 11; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 14. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M, Brühlmann P, Distler O, Schwizer W.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1259-65. PubMed ID: 17944740
    [Abstract] [Full Text] [Related]

  • 15. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
    Pace F, Sangaletti O, Zhu H, Bianchi Porro G.
    Minerva Chir; 1991 Apr 15; 46(7 Suppl):163-7. PubMed ID: 2067675
    [Abstract] [Full Text] [Related]

  • 16. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 15; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 17. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A.
    N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948
    [Abstract] [Full Text] [Related]

  • 18. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC.
    Hepatogastroenterology; 1992 Feb 26; 39 Suppl 1():27-30. PubMed ID: 1577392
    [Abstract] [Full Text] [Related]

  • 19. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
    Bianchi Porro G, Pace F, Peracchia A, Bonavina L, Vigneri S, Scialabba A, Franceschi M.
    J Clin Gastroenterol; 1992 Oct 26; 15(3):192-8. PubMed ID: 1479161
    [Abstract] [Full Text] [Related]

  • 20. Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over study.
    Ducrotté P, Guillemot F, Elouaer-Blanc L, Hirschauer C, Thorel JM, Petit A, Hochain P, Michel P, Cortot A, Colin R.
    Am J Gastroenterol; 1994 May 26; 89(5):717-21. PubMed ID: 8172144
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.